Choon-Gon Jang

Title: Choon-Gon Jang: Innovator in Pharmaceutical Composition for Addiction Treatment

Introduction

Choon-Gon Jang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of addiction treatment. His innovative work focuses on utilizing berberine as an effective ingredient in preventing and treating addiction to morphine.

Latest Patents

Choon-Gon Jang holds a patent for a pharmaceutical composition that contains berberine as the active ingredient. This composition is designed to prevent and treat addiction to morphine, as well as to inhibit the development of tolerance to its analgesic effects. The patent highlights the inhibitory effect of berberine on psychological dependence associated with abused drugs, including morphine. The composition is effective in addressing symptoms of morphine addiction and can be applied without affecting the analgesic properties of morphine during single administration.

Career Highlights

Choon-Gon Jang is affiliated with Sungkyunkwan University, where he continues to advance research in pharmaceutical sciences. His work has garnered attention for its potential impact on addiction treatment and the development of safer therapeutic options.

Collaborations

Choon-Gon Jang collaborates with Seok-Yong Lee, who is also involved in research related to addiction and pharmaceuticals. Their partnership enhances the scope and depth of their research endeavors.

Conclusion

Choon-Gon Jang's innovative contributions to the field of pharmaceuticals, particularly in addiction treatment, underscore the importance of research in developing effective therapies. His work with berberine represents a significant advancement in addressing the challenges of drug addiction.